The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Cardiac AAV9-S100A1 Gene Therapy Rescues Post-Ischemic Heart Failure in a Preclinical Large Animal Model
Open accessAbstract
A protein that regulates cellular calcium, delivered percutaneously to the heart by gene therapy, improves cardiac function in pigs with heart failure and may also be effective in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Successful cardiac transduction in large species requires surgical and catheter-based approaches that can preferentially target the heart”
From Small and large animal models in cardiac contraction research: advantages and disadvantages (2014) · cites this paper as Pleger, et al., 2011
In the citing paper
“Heart failure can be induced in swine by a variety of methods such as rapid pacing (Lacroix, et al., 2002) and myocardial infarction (Pleger, et al., 2011).”
From Small and large animal models in cardiac contraction research: advantages and disadvantages (2014) · cites this paper as Pleger, et al., 2011
In the citing paper
“Myocardial gene deliveries have been performed with the aid of AAVs with methods that deliver the vectors preferentially to the myocardium such as myocardial injections (H. Su, et al., 2008), direct intracoronary (Kaspar, et al., 2005), and selective retroinfusion coupled with coronary artery occlusion (Pleger, et al., 2011; Raake, et al., 2008).”
From Small and large animal models in cardiac contraction research: advantages and disadvantages (2014) · cites this paper as Pleger, et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Cardiac excitation–contraction coupling
Bers, D., & Despa, S. (2002) · Nature · doi:10.1038/415198a · Cited by 4,927
The epidemiology of heart failure: The Framingham Study
Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,246
Flather, M. D., Yusuf, S., Køber, L., Pfeffer, M. A., Hall, A. S., Murray, G. D., Torp-Pedersen, C. T., Ball, S. G., Pogue, J. M., Moyé, L. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02212-1 · Cited by 1,585
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.
Gwathmey, J. K., Copelas, L., MacKinnon, R., Schöen, F. J., Feldman, M. D., Grossman, W., & Morgan, J. P. (1987) · Circulation Research · doi:10.1161/01.res.61.1.70 · Cited by 924
Energy metabolism in heart failure
Ventura‐Clapier, R., Garnier, A., & Veksler, V. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055095 · Cited by 514
Haghighi, K., Kolokathis, F., Pater, L., Lynch, R. A., Asahi, M., Gramolini, A. O., Fan, G.-C., Tsiapras, D., Hahn, H. S., Adamopoulos, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17892 · Cited by 478
Greenberg, B., Quiñones, M. A., Koilpillai, C. J., Limacher, M. C., Shindler, D. M., Benedict, C. R., & Shelton, B. J. (1995) · Circulation · doi:10.1161/01.cir.91.10.2573 · Cited by 473
McMurray, J. J. V. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp0909392 · Cited by 464
Müller, O. J., Kaul, F., Weitzman, M. D., Pasqualini, R., Arap, W., Kleinschmidt, J. A., & Trepel, M. (2003) · Nature Biotechnology · doi:10.1038/nbt856 · Cited by 411
Self-citation
Cited by
Sorted by citations
Items 201–233 of 233
Patterson, K. (2015) · Circulation Research · doi:10.1161/circresaha.115.307772
The role of Connexin45 in the pathogenesis of ventricular tachyarrhythmia
Fahmy, P. (2015) · The Sydney eScholarship Repository (The University of Sydney)
Katz, M. G., Fargnoli, A. S., Pritchette, L. A., & Bridges, C. R. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-417-3_8
Animal Models of Cardiovascular Disease
Sleeper, M. M. (2013) · CRC Press eBooks · doi:10.1201/b16317-4
Gene and Cell Therapy in Heart Failure
Badimón, L., Vilahur, G., & Cubedo, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45237-1_16
Gene Therapy for Nonischemic Cardiomyopathy
Regnier, M., & Moussavi‐Harami, F. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.042
Influence of Heterogeneities on Waves of Excitation in the Heart
Baig-Meininghaus, T. (2018) · doi:10.53846/goediss-7025
Gene Therapy and Genomic Application in Heart Disease
Zhu, F., & Huang, K. (2018) · Translational bioinformatics · doi:10.1007/978-981-13-1429-2_13
Preclinical Development of Gene Therapy
Giamouridis (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190605dg
Commentary: Doubling down on adeno-associated viruses for cardiac gene therapy
Ryan, C. T., & Ghanta, R. K. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.10.111
Targeting Mitochondria for Therapy of Cardiovascular Disease
Samanta, B., Banerjee, S., Nandy, S. K., & Chakraborti, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-8946-7_28
Gene and cell based therapies for the prevention and treatment of supraventricular arrhythmias
Hoffman, J. A., Trivedi, A. D., & Arora, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813704-8.00034-6
Bähr, A., Hornaschewitz, N., & Kupatt, C. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0668-1_4
Design of Caspase and MMP-Activatable Adeno-Associated Virus Vectors and Their In Vivo Application
Brun, M. J. (2020) · Rice Research Repository (Rice University)
New modalities to monitor and interfere with cardiac remodeling
Driessen, H. E. (2020) · doi:10.33540/408
Animal Models of Cardiovascular Disease
Sleeper, M. M. (2021) · CRC Press eBooks · doi:10.1201/9780429439964-29
Wu, Z., Cao, L., Cao, Z., Wang, T., Wang, Z., Wang, X., & Xiao, W. (2021) · doi:10.22541/au.161909759.96594467/v1
Recombinant Adeno-Associated Virus for Cardiac Gene Therapy
Kok, C., Ravindran, D., & Kizana, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-86140-7_9
Molecular mechanisms of TBX5-related conduction disorders
Rathjens, F. S. (2021) · doi:10.53846/goediss-8451
(2011) · Human Gene Therapy · doi:10.1089/hum.2011.2519
Reparative therapies for the failing heart
Jabbour, R. J., & Lyon, A. R. (2022) · doi:10.1093/med/9780198766223.003.0068
Cardiac Gene Delivery in Large Animal Models: Selective Retrograde Venous Injection
Schlegel, P., & Raake, P. W. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2707-5_13
Self-citationSchoger, E. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9564
SUMO interacting motif (SIM) of S100A1 is critical for S100A1 post-translational protein stabilityPreprint
Jebessa, Z. H., Glaser, M., Zhao, J., Schneider, A., Seenivasan, R., Busch, M., Ritterhoff, J., Wade, R. C., & Most, P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.18.524665
Self-citationKehr, D., Salatzki, J., Krautz, B., Varadi, K., Birkenstock, J., Schlegel, P., Gao, E., Koch, W. J., Riffel, J. H., André, F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.03.529004
Self-citationRocha, A. G., Yu, T., Loveland, M., Patel, D. H., & Rodgers, B. D. (2025) · The AAPS Journal · doi:10.1208/s12248-025-01145-3
Cell and Gene Therapy in Heart Failure
Badimón, L., Mendieta, G., Vilahur, G., & Borrell-Pagés, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-96562-3_15
New biomarkers and therapeutic targets in left ventricular hypertrophy
Evaristi, M. F. (2017) · theses.fr (ABES) · doi:10.70675/0d048706z75d9z4ea2za46fz8f14c110ade5
Thérapie génique de l'insuffisance cardiaque par les phosphodiestérases
Bourcier, A. (2019) · theses.fr (ABES) · doi:10.70675/19ee12d6z21e8z440fza3cfz9b22674b5d02
Etude des effets thérapeutiques de la protéine X du virus Borna chez la souris SOD1G93A
Tournezy, J. (2024) · theses.fr (ABES) · doi:10.70675/6679c9cez7694z4a71z84a3za0e24b70e3eb
Siddiqui, S., Parab, S. B., & Bhatt, L. K. (2026) · Biotechnology Journal · doi:10.1002/biot.70262
Calcium dysregulation in diabetic cardiomyopathy & heart failure with preserved ejection fraction
Ali, A., Sharma, V. M., & Aguilar-Sánchez, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1872513
Metadata
- Authors
- Pleger, S. T., Shan, C., Ksienzyk, J., Bekeredjian, R., Boekstegers, P., Hinkel, R., Schinkel, S., Leuchs, B., Ludwig, J., Qiu, G., Weber, C., Raake, P., Koch, W. J., Katus, H. A., Müller, O. J., & Most, P.
- Affiliations
- Heidelberg University (DE)
- LMU Klinikum (DE)
- German Cancer Research Center (DE)
- Thomas Jefferson University (US)
- Corresponding author
- Müller, Oliver J.
- Most, Patrick
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2011-07-20
- Volume
- 3
- Issue
- 92
- Pages
- 92ra64-92ra64
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC4095769
- OpenAlex
- W2110557028
- Cited by
- 234
- References
- 49
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 14 · 2021: 15 · 2020: 17 · 2019: 16 · 2018: 14 · 2017: 16 · 2016: 19 · 2015: 22 · 2014: 15 · 2013: 22 · 2012: 24
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01 HL 56205, R01HL061690, R01HL92130-02S1, R01HL056205, R01 HL92130, R01HL092130, P01HL075443)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- S100A1, AAV9 gene therapy, cardiac gene therapy, heart failure, myocardial infarction, coronary artery occlusion, sarcoplasmic reticulum calcium handling, cardiac contractility, left ventricular remodeling, energy homeostasis, domestic pigs
- MeSH terms
- Dependovirus, Animals, Calcium, Disease Models, Animal, Energy Metabolism, Heart Failure, Heart Function Tests, Homeostasis, Humans, Myocardial Infarction, Myocardium, S100 Proteins, Organ Specificity, Sarcoplasmic Reticulum, Genetic Therapy, Biomarkers, Myocardial Ischemia, Gene Transfer Techniques, Myocytes, Cardiac, Sus scrofa
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
